
-
Shipowner linked to giant Beirut port blast held in Bulgaria
-
E. Timor police clash with protesters over plan to buy vehicles for MPs
-
Israel launches ground assault on Gaza City
-
Malawi votes in battle of two presidents as economic crisis bites
-
2025 summer was Spain's warmest on record: weather agency
-
Gout of this world? Australian teen sprinter set for first real test
-
Smoke-dried bodies could be world's 'oldest mummies': study
-
Afghan gets life in prison for jihadist knife murder in Germany
-
Trump bringing $15 bn lawsuit against New York Times
-
Juan Mata moves to Melbourne from Australian rivals
-
UN investigators say Israel committing 'genocide' in Gaza
-
Israel bombards Gaza City as UN probe accuses it of 'genocide'
-
Rubio asks Qatar to stay as mediator after Israel strike
-
Drug cheats put India Olympic bid and careers at risk
-
East Timor police fire tear gas on second day of car purchase protests
-
Austria hit with fresh spy claims after govt promises law change
-
Floods devastate India's breadbasket of Punjab
-
In mega-city Lagos, 20 million count on just 100 ambulances
-
FBI chief Kash Patel faces Senate panel
-
Trump says bringing $15 bn lawsuit against New York Times
-
Israel sets Gaza 'on fire' as Rubio warns days left for deal
-
Phillies clinch first MLB division by beating Dodgers
-
'Nothing here': Lack of jobs forces young Nepalis abroad
-
Rubio asks Qatar to stay as mediator after Israeli strike
-
Trump set for unprecedented second UK state visit
-
Lower US tariffs on Japan autos kick in
-
Revamped Bayern face early test as Chelsea come to town
-
Papua New Guinea, Australia to vow mutual defence in new treaty
-
Malawi election a battle of two presidents
-
Asian markets rise as traders prepare for expected US rate cut
-
Malawi votes in a rematch between two presidents as economic crisis bites
-
Australia says social media ban will not age test all users
-
Poland's Nawrocki talks drone defence in Paris and Berlin
-
Trump's fossil fuel agenda challenged in youth climate suit
-
PSG fear impact of injuries as they put Champions League title on the line
-
US Senate confirms Trump aide to Fed as politics loom over rate meeting
-
Papua New Guinea, Australia will commit to mutual defence
-
Trash, mulch and security: All jobs for troops in Washington
-
Moderna Announces Updated COVID-19 Vaccine Against LP.8.1 Variant Generates Strong Immune Response in Humans
-
Highlander Silver Reports Results of Step-Out Drilling at Bonita: 24.8m at 7.43 g/t Au and 16.45 g/t Ag; 40.4m at 3.42 g/t Au and 16.93 g/t Ag
-
Aprecia and Apprentice.io Partner to Scale Pharmaceutical 3D Printing Manufacturing
-
5E Advanced Materials Completes Supply Chain Trial
-
Conga Appoints Richard Boylan as President and Chief Operating Officer
-
Empire Metals Limited Announces Company Update
-
WEI Achieves Pinnacle Partner Tier as a Broadcom Reseller for VMware Solutions
-
DEEP Robotics Leads the Industrial Robot Dog Race, Demonstrating Strong Capabilities from Power Grid Inspection to Plateau Scientific Exploration
-
Why Leaders Across Industries Are Trusting and Building Good Driver Mutuality
-
Tocvan Announces Commencement Of Field Work And Airborne Magnetics Survey At Gran Pilar Gold Silver Project; Drilling And Trenching Prep Accelerate Discovery & Pilot Mine Production
-
NFL legend Brady to play in March flag football event at Riyadh
-
Lower US tariffs on Japan autos to take effect Tuesday

US greenlights pig kidney transplant trials
Two US biotech companies say the Food and Drug Administration has cleared them to conduct clinical trials of their gene-edited pig kidneys for human transplants.
United Therapeutics along with another company, eGenesis, have been working since 2021 on experiments implanting pig kidneys into humans: initially brain-dead patients and more recently living recipients.
Advocates hope the approach will help address the severe organ shortage. More than 100,000 people in the United States are awaiting transplants, including over 90,000 in need of kidneys.
United Therapeutics's approval, announced Monday, allows the company to advance its technology toward a licensed product if the trial succeeds.
The study authorization was hailed as a "significant step forward in our relentless mission to expand the availability of transplantable organs," by Leigh Peterson, the company's executive vice president.
The trial will initially enroll six patients with end-stage renal disease before expanding to as many as 50, United Therapeutics said in a statement. The first transplant is expected in mid-2025.
Meanwhile, rival eGenesis said it had received FDA approval in December for a separate three-patient kidney study.
"The study will evaluate patients with kidney failure who are listed for a transplant but who face a low probability of receiving a deceased donor offer within a five-year timeframe," the company said.
Xenotransplantation -- transplanting organs from one species to another -- has been a tantalizing yet elusive goal for science.
Early experiments in primates faltered, but advances in gene editing and immune system management have brought the field closer to reality.
Pigs have emerged as ideal donors: they grow quickly, produce large litters, and are already part of the human food supply.
United Therapeutics said trial patients would be monitored for life, assessing survival rates, kidney function, and the risk of zoonotic infections -- diseases that jump from animals to humans.
Currently, there is only one living human recipient of a pig organ: Towana Looney, a 53-year-old from Alabama who received a United Therapeutics kidney on November 25, 2024.
She is also the longest-surviving recipient, having lived with a pig kidney for 71 days as of Tuesday. David Bennett of Maryland received a pig heart in 2022 and survived 60 days.
M.A.Colin--AMWN